Cargando…

Analysis of the Clinical Effect of Combined Drug Susceptibility to Guide Medication for Carbapenem-Resistant Klebsiella pneumoniae Patients Based on the Kirby–Bauer Disk Diffusion Method

OBJECTIVE: To evaluate the in-vitro antibacterial activity of drug combinations against carbapenem-resistant Klebsiella pneumoniae (CRKP) and to explore the guiding significance of the combined drug susceptibility results for determining the clinical efficacy in patients with CRKP infection. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Huijuan, Liu, Jingxian, Jiang, Xueyan, Chen, Feng, Lu, Xiaotong, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812027/ https://www.ncbi.nlm.nih.gov/pubmed/33469322 http://dx.doi.org/10.2147/IDR.S282386

Ejemplares similares

Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
por: Yang, Xianggui, et al.
Publicado: (2019)

A Twist to the Kirby-Bauer Disk Diffusion Susceptibility Test: an Accessible Laboratory Experiment Comparing Haloferax volcanii and Escherichia coli Antibiotic Susceptibility to Highlight the Unique Cell Biology of Archaea
por: Schiller, Heather, et al.
Publicado: (2022)

Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae
por: Qin, Xuan, et al.
Publicado: (2004)

A New Twist to the Kirby-Bauer Antibiotic Susceptibility Test Activity—Increasing Antibiotic Sensitivity of Pseudomonas fluorescens through Thermal Stress
por: Gerbig, Donald G., et al.
Publicado: (2013)

Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
por: Mulroney, K. T., et al.
Publicado: (2017)

Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio
por: Golikova, Maria V., et al.
Publicado: (2022)

Evaluation of in vivo antibacterial drug efficacy using Caenorhabditis elegans infected with carbapenem-resistant Klebsiella pneumoniae as a model host
por: Yao, Huijuan, et al.
Publicado: (2022)

Comparative Evaluation of Antimicrobial Efficacy of Herbal Formulations of Septilin and Triphala with Conventional 2% Chlorhexidine on Root Canal and Oral Commensal Bacteria using Kirby Bauer Method: An in-vitro Study
por: Ahmed, Shadab, et al.
Publicado: (2022)

Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
por: Tenover, Fred C., et al.
Publicado: (2006)

Prediction of Prognosis in Adult Patients With Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Chen, Jihui, et al.
Publicado: (2022)

Actividad antimicrobiana del extracto crudo de Pseudocallyma alliaceum (Ajo de monte) en microorganismos de importancia clínica mediante el método difusión en agar. (Kirby-Bauer) : /
por: Bravo Ramos, josé Luis
Publicado: (2015)

Single or in Combination Antimicrobial Resistance Mechanisms of Klebsiella pneumoniae Contribute to Varied Susceptibility to Different Carbapenems
por: Tsai, Yu-Kuo, et al.
Publicado: (2013)

Author Correction: Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
por: Mulroney, K. T., et al.
Publicado: (2018)

Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae
por: Bovo, Federica, et al.
Publicado: (2023)

Carbapenem-Resistant Klebsiella pneumoniae Among Patients with Ventilator-Associated Pneumonia: Evaluation of Antibiotic Combinations and Susceptibility to New Antibiotics
por: Ramadan, Raghdaa A, et al.
Publicado: (2022)

Successful treatment of hypervirulent Klebsiella pneumoniae bacteremia with combination carbapenem and rifampicin
por: Lin, Yong-Chun, et al.
Publicado: (2021)

Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae
por: Önal, Uğur, et al.
Publicado: (2023)

1656. Klebsiella pneumoniae Antimicrobial Susceptibility to Carbapenems in Latin America Between 2000 and 2014
por: Sati, Hatim, et al.
Publicado: (2019)

Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital
por: Cubero, Meritxell, et al.
Publicado: (2015)

Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
por: Saidel-Odes, Lisa, et al.
Publicado: (2013)

No Carbapenem Resistance in Pneumonia Caused by Klebsiella Species
por: Yayan, Josef, et al.
Publicado: (2015)

Epidemiological Study of Carbapenem-resistant Klebsiella Pneumoniae
por: Lin, Di, et al.
Publicado: (2018)

Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
por: Wang, Zhe, et al.
Publicado: (2018)

Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
por: Chen, Xia, et al.
Publicado: (2020)

Combination Therapy of Ceftazidime/Avibactam for the Treatment of Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Multicenter Retrospective Study
por: Lin, Jing, et al.
Publicado: (2023)

508. Gentamicin Non-susceptibility is Associated with Persistence of Carbapenem-Resistant Klebsiella pneumoniae in the Urinary Tract
por: Luterbach, Courtney, et al.
Publicado: (2019)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
por: Hu, Dakang, et al.
Publicado: (2022)

Comparative Evaluation of Colistin Broth Disk Elution Method With Two Commercially Available Systems for Colistin Susceptibility Testing Against Carbapenem-Resistant Klebsiella pneumoniae: A Single-Center Exploratory Study
por: Singh, Arpana, et al.
Publicado: (2022)

Rapid Nanopore Assay for Carbapenem-Resistant Klebsiella pneumoniae
por: Niu, Haofu, et al.
Publicado: (2019)

The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma
por: Wen, Zhongwei, et al.
Publicado: (2021)

Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19
por: Dumitru, Irina Magdalena, et al.
Publicado: (2021)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae
por: Le, Jennifer, et al.
Publicado: (2011)

Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Tian, Yuan, et al.
Publicado: (2021)

Synergistic Combination of AS101 and Azidothymidine against Clinical Isolates of Carbapenem-Resistant Klebsiella pneumoniae
por: Sung, Chung-Lin, et al.
Publicado: (2021)

In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates
por: Abdel-Halim, Mahmoud Saad, et al.
Publicado: (2022)

234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria
por: Rojas, Laura J, et al.
Publicado: (2019)

The Emergence of Klebsiella pneumoniae with Reduced Susceptibility against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria
por: Akinyemi, Kabiru O., et al.
Publicado: (2021)

Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae
por: Bulman, Zackery P., et al.
Publicado: (2021)

Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
por: Micozzi, Alessandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8tsuuns7s754gkunc99pofdo0t